Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other financing activities (2020 - 2024)

Historic Other financing activities for Fennec Pharmaceuticals (FENC) over the last 6 years, with Q1 2024 value amounting to $1.7 million.

  • Fennec Pharmaceuticals' Other financing activities changed N/A to $1.7 million in Q1 2024 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is 5790000.0% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Other financing activities stood at $1.7 million for Q1 2024.
  • In the past 5 years, Fennec Pharmaceuticals' Other financing activities registered a high of $1.7 million during Q1 2024, and its lowest value of $23000.0 during Q2 2020.
  • Moreover, its 3-year median value for Other financing activities was $156500.0 (2020), whereas its average is $519000.0.